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INTRODUCTION
Seizures  have  been recognized since  ancient  days.  One  of  the 
earliest  descriptions  of  generalized  tonic-clonic  seizure  was  recorded 
over 3000 years ago in Mesopotamia and it was attributed to the God of 
the Moon. Epileptic seizures were also described in ancient cultures of 
India, China and Egypt. 
The word seizure is derived from Latin word "sacire", meaning, 
"to take possession of" indicating that the person having a seizure is 
possessed or at least out of control.
A  seizure  is  a  paroxysmal  self  limited  event  caused  by  an 
excessive electrical discharge of central nervous system. Epilepsy is a 
disorder characterized by recurrent seizures. A First Unprovoked Seizure 
(FUS) is a first seizure episode occurring in an individual without an 
identified proximate precipitant and it excludes seizures occurring after 
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an  acute  insult  to  the  central  nervous  system  or  with  generalised 
systemic metabolic disturbance of the body1. Unprovoked seizures can 
be further classified into: Remote symptomatic seizure (associated with 
stroke,  head  injury,  tumour,  infection  etc)  and  idiopathic  seizures 
(without  history  of  neurological  insult  or  a  neurological  deficit 
presumed to be present from birth) 1.
                  A first seizure is a frightening event for families and friends. 
But the patients may have a certain degree of confusion and reluctance 
to  seek attention.  The consequences  of  a  diagnosis  of  “epilepsy” are 
serious both for the patients and their families. In the management of 
epilepsy,  it  is  important  to  humanely  guide  and counsel  the  anxious 
patients. The consequences of a diagnosis and treatment must outweigh 
the risks of seizures recurrence2.
The incidence of single seizure is 5% in a general population3, 4. 
Until recently, the long term anti epileptic drug therapy was started soon 
after a single seizure of any type based on the belief that all seizures 
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were likely  to  recur  and that  seizures  could be dangerous and could 
cause brain damage. 
                The antiepileptic drugs were also thought to be safer and 
effective  in  prevention  of  further  episodes  of  seizures  and  thereby 
altering the long term prognosis after the single seizure. 
Through various studies it was found that FUS had a recurrence 
rate of only 30-40% in 3 to 5 years1,  5,  6.  But once the patient had a 
second seizure, the risk of third seizure would be 73% and the risk of 
fourth would be 76% after a third seizure5. So it is implied that once a 
patient has more than one seizure episode, the risk of having subsequent 
seizures are quite high and hence patients  should be treated after the 
second seizure7, 9. 
9
Many clinical trials on FUS  revealed the following facts :
1) Anti  epileptic  drugs  are  potentially  toxic  producing 
physical,  cognitive,  psychological  and  teratogenic 
manifestations2. 
2) The initiation of anti epileptic drugs immediately after 
the FUS might not alter the long term prognosis  of seizure 
recurrence8. 
3) The  initiation  of  the  Anti  Epileptic  drugs  after  FUS 
may reduce the incidence of seizure recurrence in the first 3 
months after the initial seizure episode8. 
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4) So following a  FUS,  initiation  of  anti  epileptic  drug 
therapy is highly controversial and it must be based on a risk 
benefit  assessment  that  outweighs  the  risk  of  seizure 
recurrence against the side effects of long term anti epileptic 
therapy2. 
The decision regarding initiation of anti epileptic drug therapy is 
highly controversial  in view of the variable recurrence rate,  potential 
side  effects  of  anti  epileptic  drugs  and  non  alteration  of  long  term 
prognosis,  as  well  as  social  stigma of  long term medication  for  this 
chronic illness which can have profound negative effect on self esteem, 
social  opportunities  and  elimination  from  occupation,  restriction  of 
recreational  activities.  Occurrence  of  seizure  during  work  involving 
handling of heavy machineries, constructional work or deep sea water 
fishing may not only cause grievous injury but also endanger the life of 
the individual himself.  
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In the management of FUS, a few authors preferred to start anti 
epileptic  drug  therapy  immediately  after  the  first  seizure,  others 
preferred to wait for the occurrence of a second seizure. But none of the 
authors  had  taken  into  consideration  the  patients’  or  their  family 
members’  opinion.  Hence  this  present  study  analyses  patients’ 
preferences  towards  immediate  anti  epileptic  drug  therapy  following 
first  attack  of  unprovoked  generalised  tonic  clonic  seizure  and  the 
reasons for their preferences were studied with a one year follow up to 
confirm the validity of their decision. The preferences of the patients 
with relevance to their occupation, education and gender were assessed. 
The  role  of  family  members  and  appropriate  counselling  by  the 
neurologist in the decision making process were also assessed. In this 
study,  the  recurrence  rate  in  those  patients  who preferred  as  well  as 
deferred anti epileptic drug therapy were followed up for a period of one 
year. 
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Patients  with  family  history  of  seizures,  localization  related 
seizures,  myoclonic  seizures,  EEG  and  imaging  abnormalities  were 
excluded  from  this  study  and  started  on  appropriate  drug  therapy 
without  waiting  for  the  second  seizure,  since  the  recurrence  rate  is 
higher among them6. 
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REVIEW OF LITERATURE
An epileptic seizure is  defined as a sudden transitory event of 
motor, sensory, autonomic or psychic nature assumed to be the result of 
transient excessive discharge of a hyper excitable population of neurons 
in the brain10. 
An unprovoked seizure is defined as seizure occurring without an 
identified  proximate  precipitant,  which  excluded  seizures  associated 
with  an  acute  insult  to  the  central  nervous  system or  with  systemic 
metabolic disturbance11. 
Epilepsy  is  defined  as  at  least  two  episodes  of  unprovoked 
seizures occurring 24 hours apart11. 
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First  Unprovoked  Seizure  is  a  seizure  episode  without  any 
proximal precipitating event occurring for the first time. A clear history 
from the patient and an eyewitness if possible, is crucial in determining 
whether or not the episode was epileptic.  
Incidence of single seizure in general population was about 5%3, 
12  and the incidence of epilepsy is about 1-2 %12.  The recurrence rate 
after first seizure is highly variable from 17 -81%40,  41. The reason for 
this  variation  was  mainly  a  selection  bias  in  the  patient  population 
chosen for study. The majority of hospital based study estimates have 
fallen in the lower end of the range, while estimates from population 
based studies and studies in which patients were enrolled within 24 hrs 
of  seizure  fall  at  the  top.  So  the  population  based  study  was  more 
reliable15.  The recurrence was much higher in the initial few weeks or 
first 3 months after an initial attack14. 
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Until recently, it was a common practice for physicians to begin 
long term AED therapy immediately after a single seizure based on the 
belief that seizures were likely to recur, could be dangerous and could 
cause further brain damage which in turn could cause recurrence. They 
assumed that AED were safe, had few side effects and were effective in 
prevention  of  seizure  recurrence.  These  concepts  have  under  gone 
substantial  changes  due  to  various  studies  conducted  on  people  with 
FUS. 
The cumulative risk of seizure recurrence was studied by various 
authors.  The  conclusion  of  Elwes  et  al  on  the  course  of  untreated 
epilepsy predicted a recurrence rate of 27% at the end of 5 years14.
The study conducted by Hauser et al in 1982, put the recurrence 
rate at 16%, 21% and 27% at the end of first, second and third years 
respectively  after  the  index  seizure.   His  study  revealed  that  the 
recurrence rate in idiopathic group was 17% in 20 months and 26% in 
36 months. He further observed that if the patients were seizure free for 
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36 months, then it was unlikely to recur later. Age at index seizure, sex, 
seizure  type,  status  epilepticus  or  abnormality  on  neurological 
examination did not affect the seizure recurrence5.  While Anngers et al 
in 1986 arrived at a recurrence rate of 36%, 48% and 56% at first, third 
and  fifth  years  respectively  from  the  index  seizure16.  Shinnar  et  al 
configured in 1996 a recurrence rate of 29%, 37%, 42% and 44% at the 
end of first, second, fifth and eighth years respectively17.
Gowers, way back in 1881, in a follow up study on 160 patients 
found the recurrence rate to be around 33% in one month, 50% in 3 
months and 87% in one year. He further said that after a second seizure, 
the  intervals  between  successive  seizures  tended  to  decrease  and 
concluded that “seizures beget seizures” (i.e. once a major attack has 
occurred, the brain might more readily undergo further attacks) 36. This 
was also been substantiated by various studies. A study by Elwes et al 
showed the recurrence rate to be 33% in the first month and 50% in first 
three months and 87% in one year14 thus, agreed on many aspects of the 
observations and views expressed by Gower36. 
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Hausser et al arrived at a recurrence rate of 32% in three months, 
41% in 6 months, 57% in one year, 73% in 4 years. Patients who did not 
have a recurrence in 4 years, had no further seizures for additional 3 
years15. 
In a study conducted by Shinnar et  al,  median time to seizure 
recurrence was 6.2 months,  the cumulative risk of seizure recurrence 
was 66% at end of first year, 70% at the end of third year and 81% at the 
end of fifth year. Majority of seizures occurred in the first 6 months with 
most of the attacks occurring in the initial 3 months. So AEDs if at all 
given were useful only in the first six months8.
In a multicentered randomized study conducted by Musico et al, 
the chance of achieving one year remission was 82% in patients treated 
at first seizure, 84%   in patients treated at the time of seizure relapse. 
Similarly the chance of achieving 2 year remission was 60 % in patients 
treated at first seizure and 59% in patients treated at the time of seizure 
relapse26.  These  findings  were  confirmed  by  various  other  studies  in 
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which untreated patients tended to achieve seizure remission similar to 
those under treatment immediately after the seizure.
The risk of recurrence after a first single unprovoked seizure was 
more  or  less  similar  in  treated  as  well  as  untreated  cases.  In  a 
randomized multi centric study of immediate and deferred anti epileptic 
drug  treatment  in  1847  patients  with  single  seizures,  Marson  et  al 
concluded after a 5 year follow up, 76% of patients in the immediate 
treatment group and 77% of those in the deferred treatment group were 
seizure free between 3 and 5 years after randomization. The patients in 
both the groups did not differ with respect to quality of life outcomes or 
serious complications18.  Similarly studies conducted by Shinnar  et  al, 
Wolf and Bulloch et al showed no difference between the preferred and 
deferred treatment groups19, 20, 21. 
Ettore Beghi in a study of treatment of single seizures observed 
that the chance of achieving one year remission was 82% in patients 
treated  at  the  first  seizure  and  84%  in  patients  treated  after  seizure 
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relapse. Similarly the chance of achieving 2 year remission was 60% 
and 59%1. The First Seizure Trial Group after a study on treatment of 
first tonic clonic seizures observed that the relapse rate is 87% and 68% 
in  the  first  and second year  in  the  treated  group and 83% and 60% 
respectively  in  the  untreated  group22.  Also  in  a  study  conducted  at 
NIMHANS in 1993,  the  cumulative  risk of  recurrence in  the  treated 
group was 23%, 30%, 32%, 33% and 33% as compared to 28%, 36%, 
40%, 43% and 45% at 1, 6, 12, 24 and 36 months respectively in the 
untreated group24. 
Study conducted by Camfield et al in 1989 concluded that one 
year  of  daily  treatment  with  carbamezipine  significantly  reduced  the 
recurrence rate after a first afebrile seizure in children compared with 
the  untreated  group,  in  a  randomized  open  trial.  The  same  authors 
concluded in June 2002 after a 15 year follow up study that long term 
outcome was unchanged and subsequent clinical course, remission rate 
were  not  improved  in  comparison  with  the  untreated  group  and 
suggested that diagnosis and treatment of epilepsy must be delayed until 
there have been at least two unprovoked seizures7. 
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Similar views were expressed by Musico M et al after a multi-
centered  randomized  open trial.  They  concluded that  patients  treated 
after the first seizure and those treated after seizure relapse had the same 
time dependant probability of achieving 1 and 2 seizure free years43. 
Duchowny M et al also believed that AED therapy reduced the 
risk of recurrence for the first 3 months only and was not associated 
with a significant benefit after more than 3 months. They also concluded 
that the benefit of early medical therapy was short lived since there was 
no  evidence  that  immediate  treatment  induces  earlier  or  sustained 
remission46.
Marson A et al of MESS study group on immediate vs deferred 
AED therapy concluded after  a  5  year  follow up study that  43% of 
patients in the treated group and 53% of patients in the deferred group 
had seizures. The rate of remission was similar in both the groups. The 
study concluded that little was lost in the long run by deferring treatment 
in a patient who presented with a first seizure18.
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From the above studies on FUS it was concluded that untreated 
patients tend to achieve seizure remission in proportions similar to those 
of  patients  who  were  immediately  treated  after  the  index  seizure. 
Further the delayed initiation of treatment after the occurrence of second 
seizure  episode  had  the  same  long  term  prognosis  as  that  of  early 
initiation of treatment.  Hence we inferred that patients treated after the 
first seizure and those treated after the seizure relapse had the same time 
dependant probability of achieving 1 and 2 seizure free years. 
In  a  study  conducted  by  Hausser,  it  was  found  that  once  the 
patient developed second seizure, the risk of having a third unprovoked 
seizure was 32% at three months, 41% at 6 months, 57% at one year and 
73% at end of 4 years. Patients who did not have a recurrence within 
four  years  after  a  second seizure  would have no further  seizures  for 
additional 3 years. The risk of fourth unprovoked seizure after the third 
was 31% at three months, 48% at six months, 61% at one year and 76% 
at three years5. Thus when compared with the risk of seizure recurrence 
after first unprovoked seizure which stands at 30 – 40% in five years, 
the risk of seizure recurrence after second and third unprovoked seizures 
was quite high warranting the initiation of the AED therapy after the 
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second unprovoked seizure. 
According to Shinnar et al, the risk of subsequent seizures after 
two unprovoked seizures  rose  to  about  70%.  The cumulative  risk  of 
additional seizures after a third seizure was 66%, 70%, 81% respectively 
at the end of first, second and fifth years respectively8, 17.
In a prospective study conducted by collaborative group for the 
study of epilepsy, it was concluded that the probability of achieving one 
year remission (expressed as relative risk) was 0.76 in patients treated 
after two or more seizures, in comparison with those treated after first 
seizure. Similarly the corresponding figures for second and third year 
remissions were 0.67 and 0.66 respectively.  The risk of relapse of a first 
seizure was inherently lower than that of any further seizure (38% by 2 
years). After the second seizure, the risk of relapse increased to about 
79-96%.   The  second  year  risk  of  recurrence  varied  significantly 
according to the presence of recognized etiology of the seizure and of an 
abnormal EEG42.
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Studies  also  concluded  that  90%  of  newly  diagnosed  patients 
with epilepsy tended to achieve prolonged seizure remission and about 
40-60% of  these  enter  remission  as  soon  as  treatment  was  initiated. 
Though the AED therapy reduced the risk of seizure recurrence during 
the active phase (first 3 months), it did not alter the long term prognosis. 
The risk was lowest (24%) in patients with idiopathic or cryptogenic 
seizure and normal EEG, intermediate (48%) in those with symptomatic 
seizures  or  abnormal  EEGs,  and  highest  (65%)  in  those  with 
symptomatic  seizures  and  abnormal  EEGs7,  16,  17.  Presence  of  initial 
prolonged seizure, seizure during sleep and family history of seizure, 
increased the risk of recurrence.
Studies on the predictive value of EEG concerning the risk of 
seizure recurrence had shown contradictory results in various studies.  In 
a  study  conducted  by  Gilbert  DL et  al,  the  specificity,  sensitivity, 
positive and negative predictive values were studied. His conclusion was 
that  the  expected  information  from  EEG  was  too  low  to  affect  the 
treatment recommendation in most of the patients. So EEG should be 
ordered selectively  and not  routinely  after  first  unprovoked seizure30. 
The diagnostic aid of routine EEG findings in patients presenting with 
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first  unprovoked  seizure  had  more  relevance  only  if  the  EEG  was 
recorded close in time with the event31. EEG was more useful to make a 
diagnosis  of  focal  non epileptic and epileptic abnormalities  of a  first 
seizure32.  EEG could  be  helpful  in  supporting  the  diagnosis  in  older 
patients but should not be used to exclude diagnosis of epilepsy. EEG 
was useful in defining seizure types, quantifying risk of recurrence and 
quantifying  likelihood of  finding  diagnostic  abnormalities.  EEG with 
epileptiform abnormalities tended to have 1.5 – 3.0 fold increase in the 
risk  of  seizure  recurrence.  EEG had  up  to  4% false  positive  rate,  a 
relatively low sensitivity, a positive predict value of 2% - 3% and did 
not have any role in initial seizure management3. 
According  to  Beghi  et  al,  adverse  reactions  were  reported  in 
about a third of ambulatory patients receiving chronic AED therapy. The 
incidence of adverse effects tended to increase with increasing dosage. It 
was commonly accepted that currently available AEDs would have an 
adverse  influence  on  mental  and  behavioral  functions  particularly  in 
infants and elderly1. The side effects of AED were systemic reactions 
such as  hepatic,  bone  marrow toxicity  or  Steven Johnson syndrome, 
behavioral,  cognitive effects and teratogenicity in pregnant women1,  2. 
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Hence the  decision about  the  nature  and timing of  therapy with anti 
seizure  medication  should  be  individualized  considering  the  risk  of 
recurrence  and  the  likelihood  of  side  effects  of  the  medication  in  a 
particular patient. 
Madhusudanan  M  et  al  in  their  article  observed  that  actual 
decision  whether  or  not  to  treat  patients  who  presented  with  initial 
seizure must be individualized and dependant on probability of having a 
recurrence and on the perceived risk benefit ratio of treatment  13. But 
AED  therapy  was  indicated  in  patients  doing  risky  occupations  like 
driving or operating dangerous machinery. The above findings were of 
considerable importance because up to 30% of the patients treated with 
AED therapy experience moderate to severe side effects leading on to 
drug non compliance in 20% 28,43. 
Among people with only single seizure, the proportion in whom 
serious side effects of continuous anti seizure medication would occur, 
generally exceeds the proportion who would have an additional seizure 
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in the ensuing few years. On the other hand, among those with two or 
more unprovoked seizures,  the risk of  additional  seizures  was higher 
than the risk of side effects of medication. So people with two or more 
unprovoked  seizures  should  be  treated.  Further  the  decision  to  treat 
seizures carries with it the change in the patient’s life style along with 
driving  and  occupational  restrictions,  social  stigma  and  economic 
burden related to the cost of medications and adverse side effects usually 
occurring  within  30  days  of  AED  therapy.  The  clinical  course  and 
remission rates of first seizure were similar in treated and non treated 
cases29.  
Hermann  ST  observed  that  decisions  regarding  treatment  of 
single unprovoked seizures must balance the seizure recurrence risk, the 
potential impact of a recurrent seizure, the likelihood of adverse effects 
of treatment and the patient preference6.
Greenwood RS et al suggested that physician and family should 
weigh  the  risks  and  benefits  of  treatment  against  withholding  and 
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stopping therapy for providing a better quality of life for the patient. 
They advocated withholding of AED therapy until a second seizure9. 
The American Academy of Neurology in their recommendation 
suggested that the treatment option must be individualized based on risk 
benefit assessment that outweighed the risk of another seizure against 
the risk of chronic anti epileptic therapy after taking into account both 
medical  issues  and  patient  and  family  preference.  The  following 
recommendations  were  made  for  children  and  adolescents  who 
experienced a first seizure
1. Treatment  with  AED was  not  indicated  for  the  prevention  of  the 
development of epilepsy.
2. Treatment with AED should be considered in circumstances where 
the benefits of reducing the risk of a second seizure out weigh the 
risks of pharmacologic and psychosocial side effects2.
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The clinical review by Say RE et al, suggested the involvement 
of  patients  and  their  relatives  in  treatment  decision  recognising  the 
patients  as experts  with a unique knowledge of their  own health and 
their preferences for treatments, health states and outcomes. Increased 
patient involvement, a result of various sociopolitical changes was an 
important  part  of  quality  improvement  since  it  was  associated  with 
improved health outcome and enables doctors to be more accountable to 
the public34.
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The SIGN guidelines provided evidence based recommendation on 
the diagnosis and treatment of epilepsy45. The recommendations were
1. Ultimate judgement regarding treatment plan must be made by 
the doctor following discussion of the options with the patient, in 
light of the diagnostic and treatment choices available.
2. Diagnosis of epilepsy should be made by a neurologist or other 
epilepsy specialist.
3. A clear history from the patient and an eye witness to the attack 
could give the most important diagnostic information and should be 
the main stay of diagnosis.
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4. EEG is not routinely indicated and should not be performed to 
exclude a diagnosis of epilepsy.
5. The decision to start AED therapy should be made by the patient 
and doctor.  Anti  epileptic  drug therapy should be given if  patient 
considers the risk of recurrence unacceptable.
6. Patient should be warned of potential side effects and given clear 
instructions  to  seek  medical  attention  in  case  of  any  side  effects 
arising.
7. Dietary and other life style advice should be given.
31
8. Advice  and  information  on  epilepsy  should  be  given  to  the 
understanding  of  the  patient  making  suitable  adjustments  for 
different socio cultural contexts. The doctor should be approachable, 
communicative, knowledgeable and receptive. 
32
                   AIMS OF THE STUDY
a) To study the patients’ preference towards anti epileptic therapy 
following first attack of generalized tonic clonic seizure.
b) To  categorize  their  preferences  based  on  sex,  education  and 
occupational status of the patients.
c) To follow up the preferred and deferred group of patients for a 
period of one year and to assess the recurrence of seizure and 
their drug compliance level.
d) To give a final conclusion regarding the initiation of anti epileptic 
drug therapy based on the above said observations after adequate 
counselling of the patient and their family members.
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MATERIALS AND METHODS
This  study  was  conducted  in  the  Department  of  Neurology, 
Government  Stanley  Medical  College  Hospital,  a  tertiary  care  center 
located in  north Chennai in Tamil Nadu,  a state in south India.  This 
hospital  caters  primarily  to  the  lower  socio  economic  group. 
Unprovoked Generalized Tonic clonic Seizure (GTCS) was defined as a 
generalized  tonic  clonic  seizure  occurring  without  any  clear 
precipitating  event  and  witnessed  by  a  person.  Prospectively  all  the 
patients  with  first  attack  of  unprovoked  GTCS  who  attended  the 
outpatient  department  from September 2004 to December 2005 were 
enrolled and relevant demographic data such as age, gender, education, 
occupation and economic status were recorded. History regarding any 
injury during the seizure was also recorded. 
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INCLUSIONCRITERIA  : 
Theinclusioncriteriaadopted were:                                                  
a) First attack of unprovoked GTCS  
b) Age between 18 to 60 years 
c) Normal CT brain  
d) Time from the onset of the seizure to registration less than 30 days. 
EXCLUSION CRITERIA: The exclusion criteria were 
a) Patients with positive family history of seizures or epilepsy 
b) Seizure cluster within 24 hours 
c) Pregnant women 
d) Focal neurological deficit 
e) Abnormal CT brain.
f) Alcohol related seizures 
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EEG  was  done  in  all  the  patients  but  the  results  were  not 
considered while including the patients in the study.  Patients and the 
family members were counselled between the 8th and 30th day of seizure. 
Patients  seen  within  7  days  of  onset  of  seizure  were  put  on  tablet 
Clobazam 10 mg twice a day for 7 days before enrolling for  the study. 
Patients  and  their  family  members  were  explained  clearly  about  the 
following facts: 
a) First attack of unprovoked Generalized Tonic Clonic Seizure was 
not epilepsy (GTCS). 
b) The chance of recurrence rate of seizure was about 30%- 40%  in 
three to five years period
c) If anti epileptic drug therapy (AED) was preferred it should be 
taken for five seizure free years without missing even a single 
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day 
d) Long  term  AED  therapy  was  associated  with  some  adverse 
effects
e) Early initiation of AED therapy would not alter the long term 
prognosis
f) All those patients who deferred AED treatment initially would be 
given the drug by the hospital, in case of recurrence of seizure.
All patients belonging to both preferred and deferred group were 
given the relevant general  information regarding education,  marriage, 
work environment (related to driving, fishing, working in heights or near 
machineries, handling sharp instruments etc). 
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After adequate counselling and clarifying the doubts, the patients 
were asked about their preferences and reasons for their preferences for 
AED therapy.  If  a  patient  was  indecisive,  he/she  was  encouraged  to 
discuss with the family members and take the appropriate decision on 
the  next  visit.  Those  who  preferred  AED  were  started  on  tablet 
Phenytoin 200mg once a day and were instructed to collect  the drug 
periodically once in two weeks from the hospital. 
A seizure diary was maintained. Patients in both the groups were 
regularly followed up once in 2 months in the outpatient department. 
During follow-up visits, drug compliance, any recurrence of seizure, and 
adverse drug events were documented. 
At the end of one year all   the patients were asked to comment 
about their earlier decision regarding the initiation of AED. 
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              STATISTICL ANALYSIS                        
Demographic  characteristics  of  patients  with  first  unprovoked 
GTCS  were  given  in  frequencies  and  their  percentages.  Age,  sex, 
educational status and occupation of patients who preferred or deferred 
AED therapy were analyzed using Pearson’s Chi-square test and Yates 
corrected Chi-square test. Odds ratio were given with 95% confidence 
interval (CI). 
Reasons given by the patients  for preferring or deferring AED 
therapy were given in frequencies and their percentages. In the process 
of  decision  making,  the  decider’s  (patient’s  or  their  relative’s) 
proportional differences on preferring or deferring AED were analyzed 
using Pearson’s Chi-square test. Odds ratio was given with 95% CI.
P value less than 0.05 was taken as statistically significant.
39
RESULTS
A total of 100 patients satisfied our inclusion criteria and were 
taken up for the study. The results are given in the following tables with 
relevant graphic representations.
TABLE 1.1
DEMOGRAPHIC PROFILE OF THE PATIENTS  
- AGE GROUP ( n = 100 )
The study population consisted of 100 patients, 47(47%) were in 
the age group of under 20 years, 25(25%) were in the age group between 
21 – 30 years, 21(21%) were in the age group between 31 – 40 years and 
7(7%)  were  in  the  age  group above  40years.  Maximum  number  of 
patients were below  twenty years.
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TABLE 1.2
DEMOGRAPHIC PROFILE OF THE PATIENTS  
 - SEX DISTRIBUTION
Gender No. of patients %
Male 76 76
Female 24 24
In the study population, 76(76%) were males and 24(24%) were 
females. There was a male preponderance in the  study population.
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TABLE 1.3 
DEMOGRAPHIC PROFILE OF THE PATIENTS  
 - EDUCATIONAL STATUS 
Literacy No. of patients %
Primary 26 26
Middle school and above 74 74
The educational status of the 100 patients revealed that 26(26%) 
were educated up to primary school level and the rest 74(74%) were 
educated up to middle school and above.
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TABLE 1.4 
DEMOGRAPHIC PROFILE OF THE PATIENTS  
- OCCUPATIONAL STATUS
Most  of  our  study  population  consisted  of  manual  laborers 
62(62%)  and  rest  of  them  were  house  wives  17(17%)  and  students 
21(21%).             
                          TABLE 2
FACTORS INFLUENCING PREFERENCES OF 
AED THERAPY - AGE (n=100)
Age 
Group
Preferred 
Group (n=56)
Deferred 
Group (n=44)
Odds 
Ratio 
(95%CI)
P-Value
<20 27(48.2%) 20(45.5%) 1.00
X2  =0.01
P=0.95
21-30 14(25%) 11(25%) 0.94
31-40 10(17.9%) 11(25%) 0.67
>40 5(8.9%) 2(4.5%) 1.85
a    Test of significance  was Pearson chi-square test/Yates corrected 
     chi-square test  
b    Odds ratio with 95% Confidence Interval
The factors influencing preferences of AED therapy revealed that 
younger age group of less than 30 years dominated both preferred and 
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deferred group. Out of them 27(48%) in the preferred and 20(45%) in 
deferred group, were below 20 years. 
TABLE 3
FACTORS INFLUENCING PREFERENCES OF 
AED THERAPY – SEX (n=100)
Sex Preferred 
Group 
(n=56)
Deferred 
Group 
(n=44)
Odds 
Ratio 
(95%CI)b
P-valuea
Male 48(85.7%) 28(63.6%)
3.4(1.2-
10.1)
X2=6.58
P=0.01Female 8(14.3%) 16(36.4%)
a    Test of significance  was Pearson chi-square test/Yates corrected 
     chi-square test  
b    Odds ratio with 95% Confidence Interval
Most  of  the  males  in  the  study population  48(63%) opted for 
AED and while the majority  of the females 16(66%) did not opt for 
AED. 
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TABLE 4
FACTORS INFLUENCING PREFERENCES OF 
AED THERAPY – EDUCATION (n=100)
Education Preferred 
Group(n=56)
Deferred 
Group(n=44)
Odds Ratio
(95%CI)b
P-valuea
Primary 20(35.7%) 6(13.6%)
3.5(1.2-11.1)
X2=6.24
P=0.01
Middle 
School
And above
36(64.8%) 38(86.4%)
a    Test of significance was Pearson chi-square test/Yates corrected 
     chi-square test  
b    Odds ratio with 95% Confidence Interval
The bearing of educational back ground on initial choice of AED 
therapy indicate that people with lesser education (up to primary level) 
i.e 20(77%) preferred to undergo therapy when compared with better 
educated people (middle school and above) 38(52%) who deferred the 
AED. 
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TABLE 5
FACTORS INFLUENCING PREFERENCES OF 
AED THERAPY N - OCCUPATION (n=100)
Occupation Preferred 
Group(n=56)
Deferred 
Group(n=44)
Odds Ratio
(95%CI)b
P-valuea
House Wife 5(8.9%) 12(27.3%) 3.8(1.1-13.9) X2=5.9
P=0.01
Student 11(19.6%) 10(22.7%) 0.8(0.3-2.4) X2=0.1
P=0.71
Manual 
Labourer
40(71.4%) 22(50%) 2.5(1.1-6.2) X2=4.8
P=0.03
a    Test of significance  was Pearson chi-square test/Yates corrected 
     chi-square test  
b    Odds ratio with 95% Confidence Interval
Manual  laborers  had  a  preference  for  AED therapy  while  the 
majority of house wives and students deferred the therapy. 
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TABLE 6
FACTORS INFLUENCING PREFERENCES OF
 AED THERAPY – DECIDER (PATIENT / RELATIVE) (n=100)
Decider to 
take AED 
therapy
Preferred 
Group 
(n=56)
Deferred 
Group 
(n=44)
Odds Ratio
(95%CI)b
P-valuea
Patients 38(67.9%) 20(45.5%
2.5(1.2-6.2)
X2=5.1
P=0.02
Patients and
Relatives
18(32.5%) 24(54.5%)
a    Test of significance  was Pearson chi-square test/Yates corrected 
     chi-square test  
b    Odds ratio with 95% Confidence Interval
Majority of the patients themselves were categorical in initiation 
of AED therapy in preferred group (68%). While in the deferred group, 
55% of the patients were influenced by their relatives to defer therapy. 
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TABLE 7
AED THERAPY PREFERENCES AND
 REASONS (n = 56)
Reasons for AED preference Number of patients %
Fear of injury 6 10
Occupational Risk 20 36
Do not want a recurrence at any 
cost
30 54
In the preferred group, majority of the patients (54%) wanted to 
under go AED therapy since they did not want recurrence of attack at 
any cost since they were either living alone or could not avail medical 
help at times of emergency. They also feared loss of employment. Most 
of the males who preferred therapy were the lesser educated and manual 
laborers  involved in masonry work,  fishing or  electrical  works.  They 
feared not only injuries during seizure episode but also risk to their life 
itself. Hence they were interested in undergoing AED therapy. 
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TABLE 8
AED THERAPY DEFERRENCES AND 
REASONS (n = 44)
Reasons Number of patients %
Fear of adverse effects 25 56
Wait for the second 
attack
19 44
In the deferred group, most of the patients (56%) had a fear of 
adverse effects of AED therapy, hence deferred the treatment. 
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TABLE 9
ONE YEAR FOLLOW-UP (n=84)
        
Category No. of patients %
Preferred group 44 52
Deferred group 40 48
One year follow up was carried out in 84 patients. Out of them 
44(52%) were from preferred group and the rest were from the deferred 
group. 
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TABLE 10
RECURRENCE RATE  (One year)
Category No. of patients Recurrence %
Preferred group 44 6 14
Deferred group 40 8 20
Among them 6(14%) in the preferred group and 8(20%) in the 
deferred group experienced recurrence of seizure. 4 patients (66%) in 
the preferred and 6 patients (75%) in the deferred group, experienced 
seizure within the first three months. 
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TABLE 11
EEG ABNORMALITIES AND RECURRENCES (n = 84)
Category No. of 
patients
EEG
abnormality
% Recurrence %
Preferred group 44 13 30 4 31
Deferred group 40 11 27 3 27
EEG  were  abnormal  in  13(30%)  in  the  preferred  group  and 
11(24%) in the deferred group. 4 patients (31%) in the preferred group 
and 3 patients (27%) had experienced seizure relapse. 
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DISCUSSION
The present study was conducted in Department of Neurology, 
Government  Stanley medical  college Hospital  not  only  with the  sole 
purpose of studying patient’s attitude towards AED therapy after a first 
unprovoked GTCS but also to study the recurrence rate after a one year 
follow up. A total of one hundred new cases were included in the study 
after applying appropriate inclusion and exclusion criteria. 
Among the study population, 76% were males. In both preferred 
and  deferred  groups,  males  outnumbered  females.   This  is  probably 
because of a selection bias in a hospital based study in a developing 
country  where  more  males  report  to  hospitals  than females  because  
of  socioeconomic  reasons.  The  same  conclusion  was  drawn  by  
Hausser WA et al15,  Shinnar A et al  8,  17 and in a CAROLE study by 
Jallon P et al36. 
The median age group of patients  with FUS was less than 20 
years.  Out  of  the  study  population  34(46%)  were  below  20  years, 
drawing a parallel with  studies conducted earlier as in a CAROLE study 
by Jallon P et al36, Das CP et al12. 
Most of the study population consisted of manual laborers with 
53
education up to primary level. The choice of anti epileptic therapy was 
influenced by the educational status, occupation and gender. As reported 
in the present study, males with lower education doing manual jobs had 
more  preference  for  AED therapy  when  compared  with  their  higher 
educated counterparts.  The decision was based mainly on the fear of 
injury, the occupational risk involved there in and avoidance of seizure 
recurrence for obvious reasons.
In the management of single seizures, after the initial evaluation 
was complete,  the main decision was whether  to prescribe treatment.
(or)to wait for the recurrence. Although the medical literatures on this 
subject were controversial, several factors should be considered. 
In  1881  Gowers  suggested  that  “seizures  beget  seizures”  and 
cause more and more brain damage with each episode, which if correct, 
would  suggest  that  all  patients  should  be  treated33.  But  later  studies 
revealed  the  variable  recurrence  rate  after  first  seizure  and  the  side 
effects and social stigma involved in the long term anti epileptic drug 
therapy.
In  the  absence of  risk factors  such as  underlying  neurological 
abnormalities,  the  recurrence  following  first  attack  of  unprovoked 
GTCS was about 30 – 40%3 in three to five years.  
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The recurrence rate given by various studies at end of one year 
coincided with our study on FUS conducted at Govt. Stanley Hospital. 
In a study conducted by Hausser et al the recurrence rate at the 
end  of  one  year  was  found  to  be  20%15.  In  a  study  conducted  in 
NIMHANS, Bangalore by Gupta SK et al, the recurrence rate stood at 
23%24.  In  a  prospective  study  conducted  by  Wolf  P,  Mara  KI,  the 
recurrence rate in the first year follow up was 17.4%44. In our present 
study the recurrence rate was about 17% at the end of one year.  The 
recurrence rate among the preferred and deferred group were 14% and 
20% respectively. 
The recurrence was found to be the greatest in the initial 3 to 6 
months after the index seizure and falls to less than 10% after 2 years8. 
In the present study also the maximum number of recurrences occurred 
in the initial 3 to 6 months period in the preferred group.  In the deferred 
group, most of the recurrence occurred within first 3 months, as shown 
by Shinnar S et al in one of their studies35. In our study the recurrence 
rate was comparatively lower in the initial  3 months in the preferred 
group. 
The probability  of  achieving one year  remission,  the preferred 
and deferred group of AED therapy was given by various studies. One 
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year remission achieved in a study conducted by Beghi E et al of first 
trial group were 83% and 87%1. In the NIMHANS study by Gupta SK et 
al,  the  remission  achieved  were  77% and  72% in  the  preferred  and 
deferred  group  respectively24.  In  a  multicentered  randomized trial  by 
Musico M et al comparing the treatment of FUS with that of recurrence 
showed  that  the  long  term  effects  of  the  two  strategies  were 
approximately  similar43.   In  the  present  study,  the  probabilities  of 
achieving one year remission among the preferred and deferred groups 
were 86% and 80% respectively. 
EEG  abnormalities  were  reported  in  13  and  11  patients  of 
preferred and deferred groups out of which 4 and 3 reported recurrence 
of seizure during follow up. Studies had been inconclusive on the effect 
of EEG abnormalities on seizure recurrence. Gilbert DL concluded and 
recommended  that  EEG  should  not  be  done  routinely  after  first 
unprovoked seizure since the quantity of expected information from the 
EEG  was  too  low  to  affect  the  treatment  recommendations30.  SIGN 
guidelines also did not advocate routine EEG after a first seizure45. In 
our study also even though routine EEG was done in all patients, the 
results were not taken into consideration while planning the treatment 
approach. 
56
However  recent  well  conducted  unbiased  studies  of  prognosis 
following a FUS have also demonstrated that a significant percentage of 
patients did not have further seizures even without anti epileptic drug 
therapy.  It  seems  intuitive  that  treating  patients  with  antiepileptic 
medication,  thereby preventing further seizures,  should be better than 
not  treating  them.  Treatment  did  appear  to  reduce  risk  of  recurrent 
seizures in many but not all the treated patients. 
Hence several neurologists felt that in the management of single 
seizure  the  risk  benefit  ratio  must  be  weighed before  initiating  AED 
therapy. But who should assess it? The clinician or the affected person? 
Obviously  the  patient’s  spouse,  close  relatives  were  more  concerned 
about the health and welfare of the affected person and they could take a 
better decision suitable to the patient provided, if they were informed 
about  the  relevant  scientific  information  about  first  seizure  by  the 
neurologist. Such a decision would be more relevant and practical from 
the patient’s perspective and help to improve the health care. 
The importance of patient’s preference in treatment decision was 
stressed by Say RE in his study34. SIGN guidelines also suggested that 
ultimate judgment regarding treatment plan must be made by the doctor 
following  discussion  of  the  options  with  the  patient,  in  light  of  the 
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diagnostic and treatment choices available45.
 This  concept  was proved correct  in  the present  study also as 
evidenced by the similar recurrence rates in both preferred and deferred 
group after one year follow up. 
In  the  present  study,  one  of  the  most  important  reasons  for 
immediate preference of AED therapy was certain risky jobs the patients 
were  involved  in.  Those  patients  who  were  involved  in  fishing, 
construction work, welding, driving, handling sharp instruments as in 
carpentry feared that an attack while on work could endanger their life 
itself  and  hence  never  risked  a  recurrence.  Another  major  group  of 
patients never wanted to risk any more attack at all.  Even though few 
patients expressed that they were living alone and there would be none 
to offer any medical help at the time of emergency, most of them could 
not offer any other specific reasons. It could be the fear of seizure itself 
and the social stigma attached to it. Those who sustained major injuries 
during the first attack also feared similar injuries during recurrence and 
preferred immediate anti epileptic therapy. Thus fear of seizure, seizure 
related injuries and probably the stigma attached to epilepsy were also 
the major causes for preferring AED drug therapy.    
Most of the patients who deferred immediate AED therapy were 
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better educated females who were not involved in physical labour. An 
equal number of patients, mostly better educated housewives deferred 
the drug therapy and the reasons were
a. Fear of adverse effects of long term AED therapy. These patients 
were more concerned about the adverse effects of long term AED 
therapy and preferred to wait for the second attack.
b. Willing to wait for the second attack, as the recurrence might not 
occur in 50% of patients.
The study had shown that following first attack of unprovoked 
GTCS, approximately one half of the patients, mostly males preferred 
AED therapy because of 
(a) An ‘attack’ while at work, might harm their life
(b) Fear of major seizure-related injuries
(c) Other reasons such as living alone etc.
 Some could not give specific reasons for preferring but it might 
have been due to fear of seizure itself and the stigma attached to it. 
In the present study, the effect of the patient’s involvement in the 
treatment decision was studied. All the patients were happy in getting 
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themselves involved in the decision making of preferring or deferring 
anti epileptic drug from their own perspective. At the end of first year, 
they felt their initial decision was correct and relevant. Those who had 
recurrence of seizure in the first year follow up in the deferred group 
voluntarily came up for the treatment and those who had recurrence in 
the preferred group due to defective compliance felt guilty and promised 
to be regular. Active participation of the patients helped to improve the 
drug compliance of the patient.  The drug compliance rate among the 
patients  attending  regular  epileptic  clinic  at  Neurology  Department, 
Government Stanley Medical College Hospital, was only 62%25. But in 
our study, drug compliance among the preferred group was 85%. The 
above  said  observations  confirm  the  importance  of  involving  the 
patients and their relatives in the process of decision making regarding 
initiation of AED therapy. Further, such a self decision could avert any 
unwanted legal complications which might arise following the unilateral 
decision of the clinician. 
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CONCLUSIONS
1. Following an attack of first unprovoked seizure, lower educated 
male laborers preferred AED therapy for the fear of injury, loss of 
job or their life itself.
2. Recurrence rate  in the  treated and untreated group after  a  one 
year follow up stood at 14% and 20% respectively. 
3. Most of the recurrence in the preferred group occurred between 
the  third  to  sixth  months  and  in  the  deferred  within  3  months, 
inferring that the AED therapy did not have any role in preventing 
seizure recurrence beyond three months.
4. Effective counseling resulted in better compliance rate (85%).
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MESSAGE
Following  a  first  attack  of  unprovoked  seizure  the  decision 
regarding AED therapy may be taken by the affected patients  and 
their  close  family  members  after  adequate  counselling  by  the 
physician. Such a decision will be more relevant and suitable from the 
patients’ perspective and increases the patient’s compliance to treatment. 
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ANNEXURES
PROFORMA
Name: SerialNo: 
Age: Neuro No:
EEG No : 
Sex: Date of 
registration:
Address:
Education:
Occupation: Income:
Education of the relative:
Date of first seizures:
Time of occurrence:  day time  sleep
EEG:
CT scan
Time taken to decide about treatment: days
Decided to  start treatment
 not willing for treatment
Decision taken by  patient  relative………….
Reason to start/not willing for treatment:
Reviews:
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